Krystal Biotech (KRYS) Interest & Investment Income (2017 - 2026)

Krystal Biotech has disclosed Interest & Investment Income across 10 years of filings, most recently posting $7.8 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $7.8 million, up 5.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.7 million (down 2.32% YoY), and the FY2025 annual result was $28.2 million, down 4.84% from the prior year.
• Interest & Investment Income came in at $7.8 million for Q1 2026 at Krystal Biotech, up from $6.9 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.8 million in Q1 2026 to a low of $257000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $6.9 million (2025), against an average of $5.5 million.
• Across the five-year window, Interest & Investment Income soared 3784.29% in 2022 and declined 9.65% in 2025, its largest moves.
• Krystal Biotech's Interest & Investment Income stood at $2.7 million in 2022, then soared by 172.49% to $7.4 million in 2023, then retreated by 2.35% to $7.2 million in 2024, then decreased by 5.17% to $6.9 million in 2025, then climbed by 13.0% to $7.8 million in 2026.
• The last three Interest & Investment Income figures came in at $7.8 million (Q1 2026), $6.9 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.